ACTN2 Gene Dilated Cardiomyopathy Type 1AA Genetic Test in UAE | 2800 AED | DHA Licensed

Executive Summary & Core Metrics

Diagnostic Accuracy: Genetic test with 99.9% diagnostic reliability, processed in an ISO 9001:2015 certified laboratory (Certificate No: INT/EGQ/2509DA/3139) using validated next-generation sequencing.
VIP Mobile Phlebotomy: Hospital-grade blood sample collection at home with strict cold-chain logistics and mobile phlebotomy team available across all UAE emirates from 8 AM to 11 PM daily.
Post-Result Clinical Guidance: Specialist teleconsultation for result interpretation provided by clinical geneticists and cardiologists, ensuring comprehensive understanding of all actionable next steps.
Insurance Verification: Instant pre-authorization confirmation via WhatsApp at +971 54 548 8731 prior to sample collection, ensuring transparent coverage assessment.

Facility licensed by the Dubai Health Authority (DHA License No: 1143). All procedures comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

Test Overview & Methodology

This next-generation sequencing test comprehensively analyzes the entire ACTN2 gene for pathogenic variants causing dilated cardiomyopathy type 1AA, empowering early diagnosis, familial risk stratification, and tailored cardiology management. The test targets all coding exons and conserved splice-site regions with deep coverage to detect single nucleotide variants, small insertions and deletions, and copy number variations.

Parameter	ACTN2 NGS Test	Single‑Gene Sanger Alternative
Precision & Coverage	Full gene sequencing with copy number variation detection; all exons plus splice sites at >100x depth	Targeted analysis of known hotspots only; limited structural variant detection
Methodology	Next‑generation sequencing with validated bioinformatics pipeline and orthogonal confirmation	Conventional Sanger sequencing with manual interpretation
Turnaround Time	3–4 weeks from sample receipt	6–8 weeks typical

Physician Insight & Safety Protocols

“Genetic testing for ACTN2 provides invaluable insight into hereditary dilated cardiomyopathy risk. At DNA Labs UAE, every variant is interpreted in the context of your personal and family history under DHA-licensed supervision. A genetic finding guides but does not dictate your clinical journey — comprehensive cardiology evaluation remains essential for all management decisions.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Medication Advisory

Do not alter or discontinue any prescribed cardiac medication without direct consultation with your treating physician. Genetic results are not a substitute for ongoing pharmacological management.

Safety Exclusion Criteria & Emergency Red Flags

Exclusion Criteria: Recent blood transfusion within the past two weeks, active systemic infection, inability to provide informed consent, or known bleeding disorder that contraindicates venipuncture.
Emergency Red Flags: Sudden onset of chest pain, syncope or near-fainting episodes, severe breathlessness at rest, or palpitations accompanied by dizziness warrant immediate emergency medical attention. Call 998 without delay.

Patient FAQ & Clinical Guidance

1. What is the ACTN2 gene test and why is it important?

This NGS test comprehensively analyzes the entire ACTN2 gene for variants linked to dilated cardiomyopathy type 1AA with high precision and full coverage.

It identifies pathogenic mutations that cause the heart muscle to become enlarged and weakened, enabling early intervention, cascade screening in relatives, and personalized surveillance plans. This test is recommended for individuals with a family history of cardiomyopathy or unexplained heart failure.

2. How long does it take to receive my results?

Results are delivered within three to four weeks after sample receipt using next-generation sequencing technology with rigorous bioinformatics validation.

Once your blood sample arrives at our ISO-certified laboratory, the DNA extraction, library preparation, sequencing, and variant interpretation follow a strict 3–4 week timeline. An expedited option is not available due to the complexity of full gene analysis and orthogonal confirmation steps.

3. Is home sample collection available across the UAE?

Yes, our VIP mobile phlebotomy team provides hospital-grade home sample collection across all seven emirates with strict cold-chain compliance.

Appointments can be scheduled via WhatsApp at +971 54 548 8731 from 8 AM to 11 PM daily. The phlebotomist verifies your identity, collects the sample in a temperature-controlled transport kit, and delivers it directly to our laboratory. All services are performed under DHA home healthcare regulations.

4. Can this test help my family members?

Yes, cascade genetic testing for at-risk relatives is strongly recommended when a pathogenic ACTN2 variant is identified in a family member.

If a disease-causing variant is found, first-degree relatives such as parents, siblings, and children can undergo targeted testing to determine their own risk. Early detection enables proactive cardiac surveillance, lifestyle modifications, and preventive cardiology interventions under specialist guidance.

UAE Regulatory & Data Privacy Adherence

Data Protection & Legal Compliance Framework

DNA Labs UAE operates under the Dubai Health Authority license number 1143 and adheres fully to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for all patient genetic and clinical data. All health information processing is also governed by Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, ensuring secure electronic medical records and encrypted data transmission. Clinical testing safety and informed consent protocols comply with Federal Decree-Law No. 4 of 2016 on Medical Liability, guaranteeing patient rights and diagnostic integrity throughout the testing lifecycle.

Clinical & Logistical Metadata

Test Name	ACTN2 Gene Dilated Cardiomyopathy Type 1AA Genetic Test – Next-Generation Sequencing
Price (AED)	2,800 AED
Turnaround Time	3–4 weeks from sample receipt
Sample Type / Matrix	Peripheral whole blood (EDTA tube) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM to 11 PM
Methodology Used	Next-Generation Sequencing (NGS) with full gene coverage, CNV detection, and orthogonal confirmation
ICD-10-CM Code	I42.0
LOINC Code	21636-6
DHA Facility License & Laboratory Address	DHA License No: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| Corporate Lab Branding: DNA Labs UAE